scispace - formally typeset
Open AccessJournal Article

Leukocytes of normal pregnant women.

Efrati P, +3 more
- 01 Mar 1964 - 
- Vol. 23, pp 429-432
Reads0
Chats0
About
This article is published in Obstetrics & Gynecology.The article was published on 1964-03-01 and is currently open access. It has received 63 citations till now. The article focuses on the topics: Hemoglobinometry & Alkaline phosphatase.

read more

Citations
More filters
Journal ArticleDOI

Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome?

TL;DR: Maternal UTI is independently associated with pre-term delivery, pre-eclampsia, IUGR and CD, Nevertheless, it is not associated with increased rates of perinatal mortality compared with women without UTI.
Journal ArticleDOI

Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection

TL;DR: Qualitative differences indicate that the innate limb of the immune response is not maximally activated during normal pregnancy, and pregnant women with acute infection had more marked phenotypic and metabolic changes of leukocytes than normal pregnant women.
Journal ArticleDOI

Normal pregnancy is characterized by systemic activation of the complement system

TL;DR: It is proposed that physiologic activation of the complement system during pregnancy is a compensatory mechanism aimed at protecting the host against infection.
Journal ArticleDOI

Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction

TL;DR: The evidence for an infectious trigger is principally indirect, linking the similarities between acute atherosis in preeclampsia and atherosclerosis, the increased likelihood of developing cardiovascular disease later in life following a preeclamping pregnancy, and the association between chronic infection and atherogenesis.
Journal ArticleDOI

Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.

TL;DR: Insight is provided into the immune responses to lipid nanoparticle-formulated unmodified and pseudouridine-modified mRNAs administered systemically in vivo, and it is suggested that pseudouredidine modifications may be unnecessary for therapeutic application of mRNA in the liver.
Related Papers (5)